İçeriğe geç

Research and Publication Ethics Policy

Bayrakol Medical Publishing requires that all research involving human participants, animals, identifiable data, or sensitive materials fully comply with internationally recognized ethical, legal, and regulatory standards.

Ethics Committee Approval Requirements

  • All human studies must have prior approval from an accredited Ethics Committee (IRB / EC), including approval number, institution, and date.
  • Animal studies must comply with international animal welfare standards (e.g., Guide for the Care and Use of Laboratory Animals, ARRIVE Guidelines).
  • Clinical trials must be prospectively registered in a public registry (e.g., ClinicalTrials.gov, EudraCT, TRC).
  • Informed consent must be obtained from all human participants through written or legally accepted forms.
  • Publication consent must be obtained for identifiable patient images or personal data.
  • Compliance with data protection regulations (KVKK, GDPR, or relevant national laws) is mandatory.

Research Conduct & Scientific Integrity

  • All studies must adhere to the principles of the Declaration of Helsinki (2013 or later).
  • Data must be collected, analyzed, and reported accurately without fabrication, falsification, or manipulation.
  • Authors must be able to provide raw data, original images, protocols, or trial documentation upon request.
  • Permissions must be secured for copyrighted or third-party materials included in the manuscript.

Special Considerations

  • Retrospective studies must clearly document ethics approval or exemption.
  • Multicenter studies must obtain approval from each participating center or provide central IRB documentation.
  • AI-assisted research must disclose tools used and ensure patient privacy.
  • Studies involving vulnerable populations (children, prisoners, migrants, cognitively impaired individuals) require additional protective measures.

Conflict of Interest & Transparency

  • All financial, institutional, or personal conflicts of interest must be declared by the authors.
  • Funding sources, grant numbers, and sponsor contributions must be transparently reported.
  • Clinical trials should follow CONSORT; observational studies STROBE; systematic reviews PRISMA; animal studies ARRIVE reporting guidelines.

Publisher Compliance & Oversight

Bayrakol Medical Publishing fully adheres to the following international standards and recommendations:

  • ICMJE Ethical Guidelines
  • COPE Core Practices
  • Declaration of Helsinki
  • WAME Recommendations
  • NIH / PubMed Central Data Standards

The publisher reserves the right to request additional documentation, investigate potential ethical violations, and issue corrections or retractions when necessary.